+ Watch MDAS
on My Watchlist
EPS Ranking 96
finally mgmnt.,sales,and technical areashave their act together.
BECAUSE OF THE LAW. How can the company not rise in price?
I worked for this company and have never seen a more unprofessional and crazy top management team. They change roles like most change underware, and have no idea how to support people into success. John Bardis is more interested in wrestling than his company or employees.
Good solid company is a sector that should see heavy demand as US population ages; esp as healthcare coverage becomes to more people.
Its Revenue Cycle Management segment currently has more than 1,000 hospital customers, and its Spend Management segment manages approximately $15 billion of supply spending by healthcare providers and has more than 1,700 hospital customers. Continues to grow and help the healthcare industy become more efficient.
Hi growth based on helping healthcare systems improve revenues and decrease costs.
This company showed strong growth recently. I don't think it can match it's past performance.
MedAssets in an overlooked and unhyped recent IPO that has the synergy to succeed in the on-demand software sector. First, the company is poised to succeed regardless of a recession, economic slowdown, or continued bull market because its technology delivers solutions designed to improve operating margin, cash flow, and expense for hospitals and health systems from 1-10 percent. These factors increase the bottom line. Second, Its Revenue Cycle Management segment has more than 1,000 hospital customers, +125 customer base health systems, +2,500 acute care hospitals, and approximately 30,000 ancillary provider locations. Third, MedAssets 2006 revenue growth rate was 80%, which was nearly double the rate of Athena Health (ATHN) and 5 percent lower than Netsuite (N) two recent IPOs that have skyrocketed. Bottom line, it's not to late to establish a position in MDAS before the underwriters initiate coverage (typically positive) and the investing public catches on to this overlooked and unhyped stock.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions